Why the NHS is both the dream and the danger

For Health Tech founders, landing an NHS contract is the holy grail. The NHS is one of the world’s largest healthcare systems, with reach and credibility that can transform your startup’s trajectory. A single NHS deal can open doors with private healthcare providers, insurers and international markets.

But here’s the reality: selling into the NHS is slow, complex and expensive. Procurement cycles often take 12-24 months, with multiple layers of compliance, pilots, and decision-making committees. Even if you’ve already secured NHS pilots, turning them into paying contracts can cost far more time and money than most founders anticipate.

The risk? Burning through your cash before the first NHS invoice lands.

Understanding the hidden costs of NHS sales – and planning for them – is crucial if you want to keep your runway intact and your investors confident.

The real cost drivers of NHS procurement

NHS procurement isn’t just about proving clinical effectiveness. There are several cost buckets founders often underestimate:

Compliance and regulation

• Data security – Full compliance with NHS Digital standards and GDPR can require significant investment in IT infrastructure and audits.
• Clinical validation – Even if you’ve run trials, additional NHS-specific validation may be required.
• Regulatory approvals – CE/UKCA marking, MHRA certification, or NICE guidance can each add months and tens of thousands of pounds.

Pilots and trials

• Unpaid pilots – Many NHS trusts will ask for proof-of-concept pilots before committing, often without paying.
• Customisation costs – Integrating with existing NHS systems like EMIS or Epic is rarely straightforward.
• Staff training – Pilots often require you to invest in training NHS staff, sometimes across multiple sites.

Procurement delays

• Decision-making – Purchases may require approval at trust, regional, and sometimes national levels.
• Tender processes – Open tenders take time and can require extensive bid preparation.
• Budget cycles – Even once approved, funding may not be available until the next fiscal year.

Add these up, and it’s not unusual for startups to spend 6-7 figures chasing NHS contracts before meaningful revenue arrives.

Why investors worry about NHS-heavy models

Investors know the NHS is slow. When they see a Health Tech financial model that assumes rapid NHS adoption, red flags go up. The key risks they see are:

• Runway risk – You’ll run out of cash before contracts close.
• Dependency risk – Relying too heavily on one payer (the NHS) leaves you exposed.
• Unclear ROI – If pilots don’t convert, you’ve sunk resources without proving revenue.

That doesn’t mean investors avoid NHS-focused Health Tech altogether. But they want to see that you’ve planned for the hidden costs and balanced your model accordingly.

How to plan for NHS sales without sinking your startup

Model long delays into your cashflow

Assume at least 12-24 months for NHS contracts to convert. Build scenarios where deals take even longer. If your model still shows you surviving, you’ll reassure investors you’re realistic.

Diversify early revenue streams

Don’t wait on the NHS alone. Explore:

• Private healthcare – Faster adoption cycles and less bureaucracy.
• Corporate health programmes – Companies willing to pay for employee wellbeing solutions.
• International pilots – Other countries may offer quicker access to revenue.

These revenue streams show investors you’re not entirely NHS-dependent.

Capitalise compliance costs as milestones

Rather than listing a vague “regulatory spend,” break costs down into milestones – data audits, certifications, integration builds. This makes it clear you know what’s coming and when.

Use pilots as marketing, not just validation

Even unpaid NHS pilots have value if you leverage them. Collect testimonials, case studies, and outcome data. Use them to strengthen your investor pitch and to accelerate private deals while NHS contracts are pending.

A founder’s checklist for NHS sales readiness

Before you commit significant time and money to NHS procurement, ask yourself:

1. Have we mapped all compliance costs into our financial model?
2. Do we have alternative revenue streams to sustain us during NHS delays?
3. Have we built scenarios where pilots don’t convert – and still survived?
4. Can we clearly explain to investors why NHS sales are worth the wait?

If you can’t answer yes to these, you may need to rethink your approach before heading too far down the NHS track.

Bringing it all together

Selling into the NHS can transform a Health Tech startup – but it can also drain resources faster than you expect. The hidden costs of compliance, unpaid pilots, integration, and long procurement cycles are what catch most founders off guard.

The solution isn’t to avoid the NHS. It’s to plan for the costs, diversify your early revenue, and build financial models that anticipate delays. That way, when you do land NHS contracts, your business will still be standing – and your investors will be impressed you made it through.

At Standard Ledger UK, we help Health Tech founders:

• Forecast NHS procurement realistically.
• Build models that show investors both the costs and the opportunities.
• Plan funding strategies that balance NHS ambitions with private wins.

Because the NHS can be a springboard for growth – if you’ve planned for the journey.